Gilead Awaits EMA Verdict On Trodelvy As It Whizzes Through EU Review
Pneumococcal Vaccine & Four New Drugs Also Up For CHMP Opinion
Sponsors of six new products, including a first-in-class treatment for unresectable locally advanced or metastatic triple-negative breast cancer, will find out this week if their products are on course to be approved for use in the EU. Also, two sponsors might be asked to address last-minute questions about their drugs.
